The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 13, 2011

Filed:

Apr. 13, 2007
Applicants:

Liangxian Cao, Parlin, NJ (US);

Samit Hirawat, South Plainfield, NJ (US);

Langdon Miller, Lebanon, NJ (US);

Thomas Davis, South Orange, NJ (US);

Marla L. Weetall, Morristown, NJ (US);

Inventors:

Liangxian Cao, Parlin, NJ (US);

Samit Hirawat, South Plainfield, NJ (US);

Langdon Miller, Lebanon, NJ (US);

Thomas Davis, South Orange, NJ (US);

Marla L. Weetall, Morristown, NJ (US);

Assignee:

PTC Therapeutics, Inc., South Plainfield, NJ (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/437 (2006.01); C07D 487/04 (2006.01);
U.S. Cl.
CPC ...
Abstract

In accordance with the present invention, compounds that inhibit the expression of VEGF post-transcriptionally have been identified, and compositions, and methods for the administration and use of those compounds. provided. In one aspect of the invention, compounds useful in the inhibition of VEGF production, in the treatment of solid tumor cancer, and in reducing serum, plasma, and/or tumor VEGF levels, are provided. In another aspect of the invention, methods are provided for the inhibition of VEGF production, the treatment of cancer, and the reduction of plasma and/or tumor VEGF levels, using the compounds of the invention.


Find Patent Forward Citations

Loading…